Refined Stratification and Frontline Targeted Therapies Explored in Pediatric T-ALL
The treatment of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) has benefited from numerous advancements in survival outcomes, but there are pressing needs for better risk assessment and the use of targeted therapies in the frontline setting.